| 000 | 01719 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513095033.0 | ||
| 264 | 0 | _c19960923 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0022-1007 | ||
| 024 | 7 |
_a10.1084/jem.184.2.725 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMachleidt, T | |
| 245 | 0 | 0 |
_aFunction of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C. _h[electronic resource] |
| 260 |
_bThe Journal of experimental medicine _cAug 1996 |
||
| 300 |
_a725-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, CD _xphysiology |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aEnterotoxins |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNorbornanes |
| 650 | 0 | 4 |
_aPhosphatidylcholines _xphysiology |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPhospholipases A _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xphysiology |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type I |
| 650 | 0 | 4 |
_aShock, Septic _xprevention & control |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aThiocarbamates |
| 650 | 0 | 4 |
_aThiones _xpharmacology |
| 650 | 0 | 4 |
_aType C Phospholipases _xantagonists & inhibitors |
| 700 | 1 | _aKrämer, B | |
| 700 | 1 | _aAdam, D | |
| 700 | 1 | _aNeumann, B | |
| 700 | 1 | _aSchütze, S | |
| 700 | 1 | _aWiegmann, K | |
| 700 | 1 | _aKrönke, M | |
| 773 | 0 |
_tThe Journal of experimental medicine _gvol. 184 _gno. 2 _gp. 725-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1084/jem.184.2.725 _zAvailable from publisher's website |
| 999 |
_c8757719 _d8757719 |
||